Baylor College of Medicine has been awarded more than $31 million by the Cancer Prevention & Research Institute of Texas (CPRIT) to support new research, core facilities and recruitment of new faculty to support the fight against cancer.
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
A team of researchers at Baylor College of Medicine and Roswell Park Comprehensive Cancer Center has identified a long sought after connection between how cancer cells use glucose to generate energy and cancer growth.
Dr. Jeffrey A. Bluestone, the A.W. and Mary Margaret Clausen Distinguished Professor at the University of California San Francisco, will be the Distinguished Lecturer at the Seventh Annual McNair Symposium at Baylor College of Medicine.
The Department of Molecular and Human Genetics and the Dan L Duncan Comprehensive Cancer Center hosted their first joint U.S.-Japan Clinical Cancer Genomics and Personalized Medicine Symposium in Tokyo, Japan.
The physical and emotional tolls chemotherapy can have on a patient undergoing cancer treatment are well known, but there are many myths when it comes to managing fitness and nutrition during treatment. Nutritionist Rachel Dudley explains.
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults